982 articles in this topic
A phase 2 RCT finds ABvac40, a vaccine targeting vascular amyloid-β40, is safe and immunogenic in early Alzheimer's patients with no ARIA-E.
β-endorphin released during exercise wraps around toxic Aβ aggregates, forming a 'corona' that shields brain cells from Alzheimer's damage.
A 19-year cohort study maps how amyloid and tau shift in CSF across the full Alzheimer spectrum, pinpointing the optimal intervention window.
A Phase 4 RCT tests whether one bevacizumab injection matches two combined doses for neovascular AMD outcomes over 12 months.
From Alzheimer's to Parkinson's, a wave of novel FDA approvals is expanding treatment options for serious neurological conditions.
Psychiatrist Dr. Paul Conti outlines actionable frameworks for overcoming intrusive thoughts, bad habits, and low motivation to build lasting mental wellbeing.
Neurosurgeon Dr. Casey Halpern explains how DBS and AI are reshaping treatment of OCD, addiction, and binge eating disorder.
New research overturns assumptions: dolichoectasia, not stenosis, strongly predicts lacunar stroke and cerebral small-vessel disease progression.
A 79-year-old man developed involuntary movements weeks after carotid surgery, revealing a rare stroke complication.
A multinational study finds 56% of genetically diagnosed infants with epilepsy have variants potentially amenable to antisense oligonucleotide treatment.
A newly identified glucocorticoid-iron-α-synuclein axis drives anxiety-linked brain changes, opening fresh therapeutic targets.
MIT researchers discovered that 30% of adult brain synapses are dormant but ready to activate, reshaping how we understand lifelong learning.
